These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9501643)

  • 21. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular allergy: diagnosis and treatment.
    Butrus S; Portela R
    Ophthalmol Clin North Am; 2005 Dec; 18(4):485-92, v. PubMed ID: 16314214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New therapeutic agents marketed in 1993.
    Hussar DA
    Pa Med; 1994 Jul; 97(7):16-8. PubMed ID: 7936695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical efficacy and safety of levocarbastine++ in the therapy in children suffering from seasonal allergic rhinitis and conjunctivitis who are less than 12 year of age].
    Kurzawa R; Kossek M; Doniec Z; Mazurek H; Urbanek E; Sak-Kopytyńska I; Radliński J; Bukowczan Z
    Pol Merkur Lekarski; 1998 May; 4(23):269-72. PubMed ID: 9825660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lodoxamide in vernal keratoconjunctivitis.
    Lee S; Allard TR
    Ann Pharmacother; 1996 May; 30(5):535-7. PubMed ID: 8740338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of emedastine eyedrops on acute seasonal allergic conjunctivitis in children].
    Endre L
    Orv Hetil; 2003 Apr; 144(14):665-7. PubMed ID: 12795028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
    Johnson HG; Sheridan AQ
    Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of lodoxamide tromethamine on paraplegia that occurs after infrarenal aortic occlusion in the rabbit.
    Ball TD; Lundy EF; Zelenock GB; D'Alecy LG
    J Vasc Surg; 1987 Dec; 6(6):572-7. PubMed ID: 3694755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
    Watt GD; Bui TC; Bewtra AK; Townley RG
    J Allergy Clin Immunol; 1980 Oct; 66(4):286-94. PubMed ID: 7419830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study.
    Fahy GT; Easty DL; Collum LM; Benedict-Smith A; Hillery M; Parsons DG
    Eur J Ophthalmol; 1992; 2(3):144-9. PubMed ID: 1450659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study.
    Mann JS; Clement P; Sheridan AQ; Soryal I; Fairfax AJ; Holgate ST
    J Allergy Clin Immunol; 1985 Jul; 76(1):83-90. PubMed ID: 4008815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of lodoxamide in vernal keratoconjunctivitis.
    Das D; Khan M; Gul A; Alam R
    J Pak Med Assoc; 2011 Mar; 61(3):239-41. PubMed ID: 21465936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An efficacy study of lodoxamide treatment in allergic eye lesions].
    Giuri S; Munteanu GH
    Oftalmologia; 2000; 50(1):68-76. PubMed ID: 11021110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical trial of a new topical anti-histamine agent histimet in the treatment of seasonal allergic rhinoconjunctivitis].
    Bulycheva NA; Ekinova GM; Vasil'eva TG
    Vestn Otorinolaringol; 1998; (3):46-8. PubMed ID: 9662981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitomycin-C and vernal conjunctivitis.
    MacLeod JD
    Ophthalmology; 2000 Dec; 107(12):2127. PubMed ID: 11097580
    [No Abstract]   [Full Text] [Related]  

  • 36. [New aspects in drug therapy of ocular allergies].
    Maĭchuk IuF
    Vestn Oftalmol; 2000; 116(5):10-4. PubMed ID: 11221368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of ischemia-reperfusion injury by the allergy drug lodoxamide tromethamine.
    Parenteau GL; Clark RE
    Ann Thorac Surg; 1991 Oct; 52(4):832-8. PubMed ID: 1929638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of oxidative enzymes by anti-allergy drugs.
    White GJ
    Agents Actions; 1981 Nov; 11(5):503-9. PubMed ID: 6121476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis.
    Santos CI; Huang AJ; Abelson MB; Foster CS; Friedlaender M; McCulley JP
    Am J Ophthalmol; 1994 Apr; 117(4):488-97. PubMed ID: 8154531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vernal conjunctivitis.
    Jun J; Bielory L; Raizman MB
    Immunol Allergy Clin North Am; 2008 Feb; 28(1):59-82, vi. PubMed ID: 18282546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.